About The Medical Condition Evaluation Studies, FDA Phase 2
Find the definition of the medical term Evaluation Studies, FDA Phase 2. Evaluation Studies, FDA Phase 2 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Evaluation Studies, FDA Phase 2
| Evaluation Studies, FDA Phase 2 Medical Condition |
|---|
What's The Definition Of The Medical Condition Evaluation Studies, FDA Phase 2?
Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Benign Meningiomas ‐ A relatively common neoplasm of the central nervous system that…
- Peyer Patches ‐ Lymphoid tissue on the mucosa of the small…
- Uphill Transport ‐ The movement of materials across cell membranes and epithelial…
- Complement Activating Enzymes ‐ Enzymes present in the complement system which activate one or…
- Organizers, Embryonic ‐ The regions within an embryo that control development and differentiation.…
- Dyes, Phthalein ‐ Colored condensation products of phenols with phthalic anhydride.…
- Laminin M ‐ Large, noncollagenous glycoprotein with antigenic properties.…
- Epilepsy, Myoclonic ‐ A clinically diverse group of epilepsy syndromes characterized…
- State, Manic ‐ A major affective disorder marked by severe mood swings (manic…
- Palsy, Abducens Nerve ‐ Diseases of the sixth cranial (abducens) nerve or its nucleus…